In addition, serum samples from patients with SS or NASH differed markedly with regard to expression of the putative Dlk1-Dio3 mat miRNAs, and these differences accurately corresponded with NAFLD diagnosis. This evidence concerns the gene DIO3 and metabolic dysfunction-associated steatohepatitis.